Suppr超能文献

透析中心之间瘘管使用的差异:是否可以用病例组合来解释?

Variation in fistula use across dialysis facilities: is it explained by case-mix?

机构信息

Division of Nephrology, Tufts Medical Center, Boston, Massachusetts, USA.

出版信息

Clin J Am Soc Nephrol. 2010 Feb;5(2):307-13. doi: 10.2215/CJN.04430709. Epub 2010 Jan 7.

Abstract

BACKGROUND AND OBJECTIVES

Arteriovenous fistulas (AVFs) remain the preferred vascular access for hemodialysis patients. Dialysis facilities that fail to meet Centers for Medicare & Medicaid Services goals cite patient case-mix as a reason for low AVF prevalence. This study aimed to determine the magnitude of the variability in AVF usage across dialysis facilities and the extent to which patient case-mix explains it.

DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: The vascular access used in 10,112 patients dialyzed at 173 Dialysis Clinic Inc. facilities from October 1 to December 31, 2004, was evaluated. The access in use was considered to be an AVF if it was used for >70% of hemodialysis treatments. Mixed-effects models with a random intercept for dialysis facilities evaluated the effect of facilities on AVF usage. Sequentially adjusted multivariate models measured the extent to which patient factors (case-mix) explain variation across facilities in AVF rates.

RESULTS

3787 patients (38%) were dialyzed using AVFs. There was a significant facility effect: 7.6% of variation in AVF use was attributable to facility. This was reduced to 7.1% after case-mix adjustment. There were no identified specific facility-level factors that explained the interfacility variation.

CONCLUSIONS

AVF usage varies across dialysis facilities, and patient case-mix did not reduce this variation. In this study, 92% of the total variation in AVF usage was due to patient factors, but most were not measurable. A combination of patient factors and process indicators should be considered in adjudicating facility performance for this quality indicator.

摘要

背景与目的

动静脉瘘(AVF)仍然是血液透析患者首选的血管通路。未能达到医疗保险和医疗补助服务中心(Centers for Medicare & Medicaid Services)目标的透析中心将患者病例组合作为低动静脉瘘普及率的原因之一。本研究旨在确定透析中心之间动静脉瘘使用的变异性程度,以及病例组合在多大程度上解释了这种变异性。

设计、设置、参与者和测量:评估了 2004 年 10 月 1 日至 12 月 31 日期间在 173 家透析诊所公司(Dialysis Clinic Inc.)设施中接受透析的 10112 名患者使用的血管通路。如果血管通路用于超过 70%的血液透析治疗,则将其视为动静脉瘘。使用具有透析中心随机截距的混合效应模型评估了中心对动静脉瘘使用的影响。顺序调整的多变量模型衡量了患者因素(病例组合)在动静脉瘘率方面解释中心间差异的程度。

结果

3787 名患者(38%)使用动静脉瘘进行透析。存在显著的中心效应:7.6%的动静脉瘘使用率差异归因于中心。在病例组合调整后,这一比例降低至 7.1%。没有发现特定的中心层面因素可以解释中心间的差异。

结论

动静脉瘘的使用在透析中心之间存在差异,而患者病例组合并不能减少这种差异。在这项研究中,动静脉瘘使用率的总变异中有 92%归因于患者因素,但大多数因素是不可测量的。在判断该质量指标的中心绩效时,应综合考虑患者因素和过程指标。

相似文献

1
Variation in fistula use across dialysis facilities: is it explained by case-mix?
Clin J Am Soc Nephrol. 2010 Feb;5(2):307-13. doi: 10.2215/CJN.04430709. Epub 2010 Jan 7.
2
Arteriovenous Fistula Use in the United States and Dialysis Facility-Level Comorbidity Burden.
Am J Kidney Dis. 2020 Jun;75(6):879-886. doi: 10.1053/j.ajkd.2019.08.023. Epub 2019 Nov 22.
3
Achieving the goal of the Fistula First breakthrough initiative for prevalent maintenance hemodialysis patients.
Am J Kidney Dis. 2011 Jan;57(1):78-89. doi: 10.1053/j.ajkd.2010.08.028. Epub 2010 Nov 30.
6
Quality Improvement Targets for Regional Variation in Surgical End-Stage Renal Disease Care.
JAMA Surg. 2015 Aug;150(8):764-70. doi: 10.1001/jamasurg.2015.1126.
7
Standardized Transplantation Referral Ratio to Assess Performance of Transplant Referral among Dialysis Facilities.
Clin J Am Soc Nephrol. 2018 Feb 7;13(2):282-289. doi: 10.2215/CJN.04690417. Epub 2018 Jan 25.
8
Hispanic ethnicity and vascular access use in patients initiating hemodialysis in the United States.
Clin J Am Soc Nephrol. 2012 Feb;7(2):289-96. doi: 10.2215/CJN.08370811. Epub 2011 Nov 23.
10
Variation in nephrologist visits to patients on hemodialysis across dialysis facilities and geographic locations.
Clin J Am Soc Nephrol. 2013 Jun;8(6):987-94. doi: 10.2215/CJN.10171012. Epub 2013 Feb 21.

引用本文的文献

1
Center-Effect of Incident Hemodialysis Vascular Access Use: Analysis of a Bi-national Registry.
Kidney360. 2021 Feb 9;2(4):674-683. doi: 10.34067/KID.0005742020. eCollection 2021 Apr 29.
3
Arteriovenous Vascular Access Selection and Evaluation.
Can J Kidney Health Dis. 2016 Sep 27;3:2054358116669125. doi: 10.1177/2054358116669125. eCollection 2016.
5
Vascular access creation before hemodialysis initiation and use: a population-based cohort study.
Clin J Am Soc Nephrol. 2015 Mar 6;10(3):418-27. doi: 10.2215/CJN.06220614. Epub 2015 Jan 7.
6
Variation in the level of eGFR at dialysis initiation across dialysis facilities and geographic regions.
Clin J Am Soc Nephrol. 2014 Oct 7;9(10):1747-56. doi: 10.2215/CJN.12321213. Epub 2014 Sep 23.
7
Geographic and facility-level variation in the use of peritoneal dialysis in Canada: a cohort study.
CMAJ Open. 2014 Mar 27;2(1):E36-44. doi: 10.9778/cmajo.20130050. eCollection 2014 Jan.

本文引用的文献

1
Facility hemodialysis vascular access use and mortality in countries participating in DOPPS: an instrumental variable analysis.
Am J Kidney Dis. 2009 Mar;53(3):475-91. doi: 10.1053/j.ajkd.2008.10.043. Epub 2009 Jan 15.
3
Center effects in anemia management of dialysis patients.
J Am Soc Nephrol. 2007 Feb;18(2):646-53. doi: 10.1681/ASN.2006050433. Epub 2007 Jan 17.
4
Long-term outcomes of a fistula initiative: sustaining "fistula culture".
J Vasc Access. 2006 Apr-Jun;7(2):83-6. doi: 10.1177/112972980600700208.
5
AV fistula rates: changing the culture of vascular access.
J Vasc Access. 2005 Jan-Mar;6(1):13-7. doi: 10.1177/112972980500600104.
7
Establishment and maintenance of vascular access in incident hemodialysis patients: a prospective cost analysis.
J Am Soc Nephrol. 2005 Jan;16(1):201-9. doi: 10.1681/ASN.2004050355. Epub 2004 Nov 24.
8
Impact of surgeon and surgical center characteristics on choice of permanent vascular access.
Kidney Int. 2003 Aug;64(2):681-9. doi: 10.1046/j.1523-1755.2003.00105.x.
9
Assessing comorbidity using claims data: an overview.
Med Care. 2002 Aug;40(8 Suppl):IV-26-35. doi: 10.1097/00005650-200208001-00004.
10
Vascular access use in Europe and the United States: results from the DOPPS.
Kidney Int. 2002 Jan;61(1):305-16. doi: 10.1046/j.1523-1755.2002.00117.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验